BC-33-BM51_0.1uM Gene Set

Dataset NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
Category transcriptomics
Type drug perturbation
Description Dose=0.1uM, 5-fluoro-2-(2-fluoro-4-methylsulfanylanilino)-N-[(2S)-2-hydroxypropoxy]-1-methyl-6-oxopyridine-3-carboxamide, Mitogen-Activated Protein (MAP) Kinase Kinase (MEK) Inhibitors;Inhibitors of Signal Transduction Pathways targeting MAP2K7 (Novartis, 16666652)
External Link https://pubchem.ncbi.nlm.nih.gov/compound/16666652
Similar Terms
Downloads & Tools

Genes

12 genes differentially expressed following the BC-33-BM51_0.1uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.

increased expression

Symbol Name Standardized Value
MYL6 myosin, light chain 6, alkali, smooth muscle and non-muscle 1.05845
ID3 inhibitor of DNA binding 3, dominant negative helix-loop-helix protein 0.383159
CRYAB crystallin, alpha B 0.383159
TNNT1 troponin T type 1 (skeletal, slow) 0.245588
FTL ferritin, light polypeptide 0.22085
MYL2 myosin, light chain 2, regulatory, cardiac, slow 0.216585
TMSB10 thymosin beta 10 0.216585
PDLIM1 PDZ and LIM domain 1 0.210367
COPE coatomer protein complex, subunit epsilon 0.210367
RBP1 retinol binding protein 1, cellular 0.208591

decreased expression

Symbol Name Standardized Value
TGM2 transglutaminase 2 -0.65445
RAB7B RAB7B, member RAS oncogene family -0.22085